Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05766943 · ClinicalTrials.gov registry record · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
A NA study of Subcutaneous ICD and Myopotential Interference, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 71
- Enrollment target
- 1
- Study location
NCT05766943: Recruiting NA study of Subcutaneous ICD and Myopotential Interference, sponsored by Medical University of South Carolina.
NCT05766943 is a NA study of Subcutaneous ICD and Myopotential Interference that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 71 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05766943, a NA study of Subcutaneous ICD and Myopotential Interference, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 71 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is enrolling participants who are already implanted with a S-ICD device ( subcutaneous ICD), and are undergoing a routine outpatient clinic follow up appointment to have their S-ICD checked. The aim of the study is to see if a feature in the device can recognize muscle movement and differentiate movement from irregular heart signals. The study involves doing some simple arm exercises while collecting device data, both with this feature turn on and then with it turned off. Participants will be randomized to either have the feature turned on or off initially then it will be programmed the alternative way and the same exercise testing will be repeated. The study will involve just one visit.
Primary Outcome
The incidence of myopotential interference, assessed by subcutaneous electrogram annotated "T" marker during the tube exercise test with or without Smart Pass filter
Conditions Studied
Interventions
- DEVICE Smart Pass ON
- DEVICE Smart Pass OFF
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2023-11-06 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT05766943 shows while recruiting
NCT05766943 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 71 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with Subcutaneous ICD appearing as the primary indexed condition, and to 2 interventions - of which Smart Pass ON is the first listed.
NCT05766943 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT05766943 about?
NCT05766943 is a clinical study titled "Reduction of Myopotential Interference With Smart Pass in S-ICD Patients". This study is enrolling participants who are already implanted with a S-ICD device ( subcutaneous ICD), and are undergoing a routine outpatient clinic follow up appointment to have their S-ICD checked. The aim of the study is to see if a feature in the device can recognize muscle movement and differ...
What is the current status of trial NCT05766943?
This trial is currently recruiting. It is a NA study. The enrollment target is 71 participants. The study started on 2023-11-06. Estimated completion is 2026-12-31.
What conditions does trial NCT05766943 study?
This clinical trial studies the following conditions: Subcutaneous ICD, Myopotential Interference.
What interventions are being tested in trial NCT05766943?
The interventions under investigation include: Smart Pass ON (DEVICE), Smart Pass OFF (DEVICE).
Who is sponsoring clinical trial NCT05766943?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05766943 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05766943's enrollment target sits among peer trials
71 1102nd of 2000 higher than 898 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
- NCT06782555 · 71 participants · Phase 1
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI